MiSight® 1 Day
Start managing your child’s myopia with a comprehensive approach built around MiSight® 1 day contact lenses, the first and only soft contact lenses that are FDA approved to slow the progression of myopia* in children age 8-12 at initiation of treatment.1**
81% of eye care professionals agree myopia is one of the biggest problems impacting children's eyesight today.3
Benefits beyond standard vision correction
Managing myopia with the Brilliant Futures TM Myopia Management Program and MiSight® 1 day contact lenses can provide your child with a wide-range of benefits in addition to clear vision, including:
Potentially slowing myopia progression during their growing years1**
Offering a comfortable wearing experience2
Avoiding the worry of losing or breaking glasses
Accommodating a more active lifestyle2
Providing children who wear contact lenses a significantly better quality of life than children wearing glasses, especially regarding athletics and appearance2
An annual supply of MiSight® 1 day daily disposable lenses
Free shipping and free returns, including prescription changes
Program transparency; office visits outlined for the entire year
Access to online support tools
A mobile ap with education resources and appointment reminders
MISIGHT 1 DAY CONTACT LENSES ARE BACKED BY CLINICAL DATA.
In clinical trials, MiSight 1 day contact lenses were shown to slow the progression of myopia in children (8-12 years of age at the initiation of treatment) in two years.
Children may need a higher graduation as they grow
Adapting MiSight® 1 Day at an early stage can help slow changes in graduation ...
A closer look at your child's distance vision
What can you do when your child tells you they’re struggling to see the board at school? Or that things are beginning to look blurrier the further they get from them? One cause for this blurry distance vision could be myopia. Myopia causes light rays to focus at a point in front of the retina rather than directly on the surface, owing to elongation of the eye. Myopic progression is when prescriptions increase over time, and higher prescriptions have been linked to sight-threatening conditions later in life such as, retinal detachment, glaucoma and myopic maculopathy.1
Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.2
Focusing on your child's vision, now and in the future
Generally, myopia first occurs in school-age children and progresses until about age 20.4 According to the American Optometric Association, 34% of children ages 12-17 are myopic. This is due in part to changing lifestyles, with children spending less time outdoors and more time focusing on close objects like digital screens.
With FDA approval of a new soft contact lens, MiSight® 1 day, CooperVision will empower eye care professionals and parents to take on pediatric myopia’s* growing prevalence and severity with a proven approach scientifically designed for the challenge.
*Indications for use.Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
**Based on a clinical study in which participants were between the ages of 8 and 12 at initial fit.
1. Xu L, et al. High myopia and Glaucoma susceptibility for the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20. 2. Bourne RR, et al. Causes of vision loss worldwide, 1990-2010: a systemic analysis. Lancet Glob Health. 2013;1(6):e339-49. 3. CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 to 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S. 4. Yu L, et al. Epidemiology, genetics and treatments for myopia. Int J Ophthalmol. 2011;4(6):658-69.